"Patent trolls" — companies that profit solely by legally enforcing patents they own — are beginning to target the biotech industry, and an August 31 ruling from a US federal court of appeals in Washington, DC, is making it easier for them to do, Nature News' Erika Check Hayden says.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.